Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline licenses Amicus drug in $230M deal
GlaxoSmithKline licenses Amicus drug in $230M deal
GlaxoSmithKline licenses Amicus drug in $230M deal
Submitted by
admin
on October 29, 2010 - 11:38am
Source:
Bizjournals.com
News Tags:
Amicus Therapeutics
GSK
licensing
Amigal
Fabry's disease
Headline:
GlaxoSmithKline licenses Amicus drug in $230M deal
Do Not Allow Advertisers to Use My Personal information
